Optimum Length of Catheter in the Epidural Space for Labor Analgesia in Non-obese Women: a Randomised Controlled Trial of 4 cm Versus 5 cm

Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04946032
Collaborator
(none)
398
1
2
12.3
32.5

Study Details

Study Description

Brief Summary

Epidural analgesia was introduced to the world of obstetrics in 1909 by Walter Stoeckel. Over the following 100 years it has developed to become the gold-standard for delivery of intra-partum analgesia, with between 60 and 75% of North American parturients receiving an epidural during their labor. Effective labor analgesia has been shown to improve maternal and fetal outcomes. One aspect of catheter insertion that has not been fully evaluated, and with very little recent work undertaken, is the optimal length of epidural catheter to be left in the epidural space. Dislodgement or displacement of epidural catheter remains a significant cause for failure with analgesia. Novel methods of fixation may further reduce the risk of catheter migration. Another factor is the direction of travel within the epidural space, only 13% of lumbar catheters remain uncoiled after insertion of more than 4 cm into the epidural space.

Hypothesis: The investigators hypothesize that catheters inserted to 4 cm will have a lower rate of failure when compared to those inserted to 5 cm.

Objective: This study aims to evaluate the difference in quality of labor analgesia delivered by epidural catheters inserted to either 4 or 5 cm into the epidural space.

This study will be conducted as an interventional double-blinded randomised control trial to establish best practice.

Condition or Disease Intervention/Treatment Phase
  • Other: Epidural catheter
N/A

Detailed Description

Effective labor analgesia has been shown to improve maternal and fetal outcomes. It is of paramount importance to the obstetric anesthesiologist to optimize the quality of labor analgesia and identify any factors leading to ineffective epidural analgesia. One aspect of catheter insertion that has not been fully evaluated, and with very little recent work undertaken, is the optimal length of epidural catheter to be left in the epidural space.

Previous studies have advocated, for varying reasons, different lengths of catheter to be left in the space; these range from 2cm to 8cm. Longer epidural lengths in the space can be associated with foraminal escape, leading to unilateral block, and intravascular insertion, prompting additional manipulation. Shorter lengths have previously been associated with more frequent dislodgement. The directionality of the epidural catheter once in the space has been demonstrated to correlate with misdirection.

The aim of the study would be to standardize practice in how much epidural catheter is threaded into the epidural space.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
398 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
The anesthesiologist placing the epidural will know the group assignment.
Primary Purpose:
Treatment
Official Title:
Optimum Length of Catheter in the Epidural Space for Labor Analgesia in Non-obese Women: a Randomised Controlled Trial of 4 cm Versus 5 cm
Actual Study Start Date :
Nov 23, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 4 cm epidural catheter

The epidural catheter will be thread into the epidural space at a length of 4 cm.

Other: Epidural catheter
The epidural catheter length will vary, either 4 cm or 5 cm into the epidural space.
Other Names:
  • epidural
  • Active Comparator: 5 cm epidural catheter

    The epidural catheter will be thread into the epidural space at a length of 5 cm.

    Other: Epidural catheter
    The epidural catheter length will vary, either 4 cm or 5 cm into the epidural space.
    Other Names:
  • epidural
  • Outcome Measures

    Primary Outcome Measures

    1. Sensory block level < T10 [1 hour]

      Sensory block level to ice will be measured 1 hour after the loading dose is administered. Yes: inadequate block No: adequate block

    2. Block height discrepancy [24 hours]

      Unilateral block or block height discrepancy of >3 dermatomal levels at any time prior to delivery. Yes: inadequate block No: adequate block

    3. Re-siting of the epidural [24 hours]

      Re-siting of the epidural at any time during labour will indicate an inadequate block, for any of the following reasons: Inadequate analgesia Persistent unilateral block Persistent intravascular placement Extensive motor block Hypotension High block

    4. Adjustment of catheter length [24 hours]

      Adjustment of catheter length at any time during labour would also indicate an inadequate block.

    5. Abandonment of epidural or substitute for alternative method of analgesia after initial failure: questionnaire [24 hours]

      The epidural analgesia will also be considered inadequate if the procedure is abandoned or another method of analgesia is used. This will be recorded by the anesthesiologist.

    Secondary Outcome Measures

    1. Pain score >3 at any time during labour: questionnaire [24 hours]

      A verbal numerical rating score (VNRS) greater than 3, where 0=no pain and 10=worst pain ever.

    2. Number of epidural top-ups administered by the nursing team [24 hours]

      The number of times the labour and delivery nurse has to administer a top-up of the epidural.

    3. Number of epidural top-ups administered by the anesthesiologist [24 hours]

      The number of times the anesthesiologist has to administer a top-up of the epidural.

    4. Pain scores recorded throughout labour: questionnaire [24 hours]

      A verbal numerical rating score (VNRS), where 0=no pain and 10=worst pain ever. A verbal numerical rating score (VNRS) greater than 3, where 0=no pain and 10=worst pain ever.

    5. Hourly sensory block height assessment [24 hours]

      Hourly sensory block height assessment, using sensation to ice. This is recorded hourly as standard practice.

    6. Incidence of intravascular epidural placement [24 hours]

      Any incidence of intravascular epidural placement during labour will be recorded.

    7. Incidence of catheter dislodgement [24 hours]

      Any incidence of catheter dislodgement during labour will be recorded.

    8. Motor block using Bromage scale [24 hours]

      Bromage scale will be recorded hourly as standard practice. 3: Unable to move feet or knees 2: Able to move feet only 1: Able to just move knees 0: Full flexion of knees and feet

    9. Presence of paresthesia on insertion. [1 hour]

      Any presence of paresthesia on insertion will be recorded.

    10. Adequacy of conversion to surgical block if required for cesarean delivery: questionnaire [24 hours]

      Adequacy of conversion to surgical block in cases requiring cesarean deliveries for failed labor or fetal issues. This will be recorded by the anesthesiologist.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All women aged 18 years and above.

    • In established second stage of labor.

    • 3-7 cm dilation at time of insertion.

    • Women with BMI < 40 kg/m2

    Exclusion Criteria:
    • Known contraindication to epidural insertion.

    • Inability or unwillingness to provide written consent.

    • Previous difficult epidural insertion.

    • Previous failed epidural.

    • Imminent instrumental or operative delivery.

    • Dural puncture.

    • Combined spinal epidural analgesia.

    • High BMI > 40 kg/m2

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mount Sinai Hospital Toronto Ontario Canada M5G1X5

    Sponsors and Collaborators

    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital

    Investigators

    • Principal Investigator: Mrinalini Balki, MD, MOUNT SINAI HOSPITAL

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    ClinicalTrials.gov Identifier:
    NCT04946032
    Other Study ID Numbers:
    • 21-06
    First Posted:
    Jun 30, 2021
    Last Update Posted:
    Feb 2, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 2, 2022